Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Raquel V. Viana"'
Autor:
Raquel V. Viana, Kerri J. Penrose, John W. Mellors, Carole L. Wallis, Urvi M. Parikh, P. Richard Harrigan, Chanson J. Brumme, Kevin D. McCormick
Publikováno v:
Antimicrob Agents Chemother
Etravirine (ETR) is a nonnucleoside reverse transcriptase inhibitor (NNRTI) used in treatment-experienced individuals. Genotypic resistance test-interpretation systems can predict ETR resistance; however, genotype-based algorithms are derived primari
Autor:
Gregor Leckie, Klara Abravaya, Zowie Bagley, Ning Tang, Vihanga Pahalawatta, Carole L. Wallis, Raquel V. Viana, Shihai Huang, John Lampinen, Andrea Frank
Publikováno v:
Journal of Clinical Virology. 92:56-61
Background HIV RNA suppression is a key indicator for monitoring success of antiretroviral therapy. From a logistical perspective, viral load (VL) testing using Dried Blood Spots (DBS) is a promising alternative to plasma based VL testing in resource
Autor:
Kelley C. Gordon, P. Richard Harrigan, Chanson J. Brumme, Maritsa Scoulos-Hanson, Raquel V. Viana, Urvi M. Parikh, Carole L. Wallis, Kristen A. Hamanishi, Kerri J. Penrose, John W. Mellors
Publikováno v:
Antiviral Chemistry & Chemotherapy
Antiviral Chemistry & Chemotherapy, Vol 26 (2018)
Antiviral Chemistry & Chemotherapy, Vol 26 (2018)
Background Rilpivirine (TMC278LA) is a promising drug for pre-exposure prophylaxis of HIV-1 because of its sub-nanomolar potency and long-acting formulation; however, increasing transmission of non-nucleoside reverse transcriptase inhibitor-resistant
Autor:
P. Richard Harrigan, Chanson J. Brumme, Kristen A. Hamanishi, Urvi M. Parikh, Raquel V. Viana, Carole L. Wallis, Kerri J. Penrose, John W. Mellors, Kelley C. Gordon
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
A vaginal ring containing dapivirine (DPV) has shown moderate protective efficacy against HIV-1 acquisition, but the activity of DPV against efavirenz (EFV)- and nevirapine (NVP)-resistant viruses that could be transmitted is not well defined. We inv
Autor:
Clement Zeh, Carlos Silva de Jesus, Elias K. Halvas, John W. Mellors, Raquel V. Viana, Shanmugam Saravanan, Carole L. Wallis
Background HIV-1 sequence variation is a major obstacle to developing molecular based assays for multiple subtypes. This study sought to independently assess performance characteristics of the ViroSeq™ HIV-1 Integrase RUO Genotyping Kit (Celera, US
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc06c04a10591bfac36dafc242bfc4ca
https://europepmc.org/articles/PMC5292360/
https://europepmc.org/articles/PMC5292360/
Autor:
Klara Abravaya, Raquel V. Viana, Gregor Leckie, Carole L. Wallis, Andrea Frank, Ning Tang, Chao Qi, Vihanga Pahalawatta, Neeshan Ramdin
Publikováno v:
Journal of clinical microbiology. 53(9)
The Abbott RealTi m e MTB assay is a nucleic acid amplification test (NAAT) for the detection of Mycobacterium tuberculosis complex DNA. The sample inactivation procedure used in the assay, consisting of one part sample treated with 3 parts inactivat